Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: Treatment with pregabalin

Clinical Neuropharmacology

Volumn 31, Issue 4, 2008, Pages 241-244

  Alonso Navarro, Hortensia ^a   Fernández Díaz, Angel ^a   Martín Prieto, Manuela ^a   Ruiz Ezquerro, Juan José ^a   López Alburquerque, Tomás ^b   Jiménez Jiménez, Félix Javier ^c,d  

^a HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d NONE   (Spain)

Author keywords

Chronic inflammatory demyelinating neuropathy; Pregabalin; Therapy; Tremor

Indexed keywords

ALPRAZOLAM; AZATHIOPRINE; CLONAZEPAM; CYCLOPHOSPHAMIDE; GABAPENTIN; IMMUNOGLOBULIN; PHENOBARBITAL; PREDNISONE; PREGABALIN; PRIMIDONE; PROPRANOLOL; TOPIRAMATE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE;

AGED; ARTICLE; BLOOD TESTIS BARRIER; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; HUMAN; LIMB WEAKNESS; MALE; NAUSEA AND VOMITING; NERVOUSNESS; NEUROLOGIC EXAMINATION; PARESTHESIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETREATMENT; SEDATION; SEROLOGY; SIDE EFFECT; TREATMENT RESPONSE; TREMOR; PATHOPHYSIOLOGY; POLYRADICULONEUROPATHY;

AGED; ANTICONVULSANTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; TREMOR;

EID: 53449083574     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181585b71     Document Type: Article

References (42)

1. Marie MP. Forme spéciale de névrite hypertrophique progressive de l'enfance [in French]. Rev Neurol (Paris) 1906;14:557-559.
2. Roussy G, Levy G. Sept cas d'une maladie familiale particulie're: troubles de la marche, pieds bots at aréflexie tendineuse généralisée avec accessoirement maladress des mains [in French]. Rev Neurol (Paris) 1926;1:427-450.
3. Popow A. Une famille atteinte d'une forme particulie'e de maladie hereditaire (forme de Rossy-Levy) [in French]. Rev Neurol (Paris) 1932;2: 447-462.
4. Schaller WF, Newmann HW. Névrite interstitielle hypertrophique. Relation d'un cas avec suggestion de traitement [in French]. Rev Neurol (Paris) 1935; 63:529-539.
5. Villaret M, Haguenau J, Klotz PH. Névrite hypertrophique familiale [in French]. Rev Neurol (Paris) 1935;63:211-218.
6. Spillane JD. Familial pes cavus and absent tendon jerks: its relationship Friedreich's ataxia and peroneal muscular atrophy. Brain 1940;63: 275-290.
7. Austin JH. Observations on the syndrome of hypertrophic neuritis (the hypertrophic interstitial radiculo-neuropathies). Medicine 1956;35:187-237.
8. Andermann F, Lloyd-Smith DL, Mayor H, et al. Observations on hypertrophic neuropathy of Dejerine-Sottas. Neurology 1962;12:712-724.
9. Yudell A, Dyck PJ, Lambert EH. A kinship with the Roussy-Levy syndrome. Arch Neurol 1965;13: 432-440.
10. Gilroy J, Meyer JS, Bauer RB, et al. Clinical, biochemical and neurophysiologic studies of chronic interstitial hypertrophic polyneuropathy. Am J Med 1966;40:368-383.
11. Thomas PK, Lascelles RG. Hypertrophic neuropathy. Q J Med 1967;142:223-238.
12. Oelschlager R, White HY, Schimke RN. Roussy-Levy syndrome: report of a kindred and discussion of the nosology. Acta Neurol Scand 1971;47:80-90.
13. Shahani BT, Young RR, Adams RD. The tremor in the Roussy-Levy syndrome. Neurology 1973;23: 425-426.
14. Thomas PK, Calne DB. Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy). Ann Hum Genet 1974;38:111-153.
15. Kriel RL, Cliffer KD, Berry J, et al. Investigation of a family with hypertrophic neuropathy resembling Roussy-Levy syndrome. Neurology 1974;24: 801-809.
16. Delwaide PJ, Schoenen J. Non-hypertrophic familial neuropathy associated with intention tremor. A variety of Charchot-Marie disease? J Neurol Sci 1976;27:59-69.
17. Salisachs P. Charcot-Marie-Tooth disease associated with essential tremor: report of 7 cases and a review of the literature. J Neurol Sci 1976;28:17-40.
18. Salisachs P, Codina A, Giménez-Rold́an S, et al. Charcot-Marie-Tooth disease associated with 'essential tremor' and normal and/or slightly diminished motor conduction velocity. Report of 7 cases. Eur Neurol 1979;18:49-58.
19. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-280.
20. Said G, Bathien N, Cesaro P. Peripheral neuropathies and tremor. Neurology 1982;32: 480-485.
21. Barbieri F, Filla A, Ragno M, et al. Evidence that Charcot-Marie-Tooth disease with tremor coincides with the Roussy-Lévy syndrome. Can J Neurol Sci 1984;11:534-540.
22. Jaradeh S, Dyck PJ. Hereditary motor and sensory neuropathy with treatable extrapyramidal features. Arch Neurol 1992;49:175-178.
23. Smith IS, Furness P, Thomas PK. Tremor in peripheral neuropathy. In: Findley LH, Koller WC, eds. Handbook of Tremor Disorders. New York: Marcel-Dekker; 1995:443-454.
24. Cardoso FE, Jankovic J. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve 1993;16:904-910.
25. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981;(suppl 9):134-145.
26. Smith IS, Kahn SN, Lacey BW, et al. Chronic demyelinating neuropathy associated with benign IgM paraproteinamia. Brain 1983;106:169-195.
27. Dalakas MC, Teravainen H, Engel WK. Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies. Incidence and management. Arch Neurol 1984;41: 711-714.
28. Mendell JR, Sahenk Z, Whitaker JN, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin- associated glycoprotein antibody. Ann Neurol 1985;17:243-254.
29. Yeung KB, Thomas PK, King RHM, et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG, and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 1991;238:383-391.
30. Leger JM, Younes -Chennoufi AB, Zuber M, et al. Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunocytochemical study. J Neurol Neurosurg Psychiatry 1992;55: 112-115.
31. Smith IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Brain 1994;117:949-957.
32. Bain PG, Britton TC, Jenkins IH, et al. Tremor associated with benign IgM paraproteinaemic neuropathy. Brain 1996;119 (pt.3):789-799.
33. Pedersen SF, Pullman SL, Latov N, et al. Physiological tremor analysis of patients with anti-myelin associated glycoprotein associated neuropathy and tremor. Muscle Nerve 1997;20: 38-44.
34. Ghosh A, Young AC. Early tremor seen in IgG-paraproteinaemic neuropathy. J Neurol 2001; 248:225-226.
35. Busby M, Nithi K, Mills K, et al. The tremor associated with non-paraproteinaemic acquired demyelinating polyneuropathy: a case study. J Neurol 2003;250:486-487.
36. Budak F, Alemdar M, Kamaci S, et al. Tremor in idiopathic distal demyelinating symmetric neuropathy. Mov Disord 2005;20:1529-1530.
37. Matsuda M, Ikeda S, Sakurai S, et al. Hypertrophic neuritis due to chronic inflammatory demyelinating polyradiculonauropathy (CIDP): a post-mortem pathological study. Muscle Nerve 1996;19:163-169.
38. Ryan MM, Jones HR Jr. CMTX mimicking childhood chronic inflammatory demyelinating neuropathy with tremor. Muscle Nerve 2005;31:528-530.
39. Busby M, Donaghy M. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 2003;250: 714-724.
40. Fahn S, Tolosa S, Marín C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders Baltimore-Munich: Urban & Schwarzenberg; 1993:271-280.
41. Jiménez-Jiménez FJ, Puertas-MunĨoz I, de Toledo-Heras M. Neuroquímica y neurofarmacología del temblor esencial. In: Jiménez-Jiménez FJ, Luquin-Piudo MR, eds. Neuroquímica y Neurofarmacología de los Trastornos del Movimiento. Neurologiacute;a 2003;18 (suppl 3):37-45.
42. Zesiewicz TA, Ward CL, Hauser RA, et al. Pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 2007;22:139-141.